Stratifind is conducting a Crowdfunding offering via Netcapital Funding Portal. Support our mission here: https://bit.ly/Strat-LI


Stratifind is an oncology diagnostics company advancing RNA + DNA–based prognostic and predictive testing to improve cancer treatment decisions. Our platform goes beyond mutation detection to identify which patients are most likely to respond to specific therapies, empowering oncologists with actionable insights and enabling biopharma partners to accelerate translational research and drug development.

We also work with diagnostics innovators who are uncertain about commercialization, reimbursement, or clinical adoption—helping them navigate complexity and find the right path forward. Anchored in tissue-based gene expression and enhanced with algorithmic interpretation, Stratifind is engaging a CLIA-certified lab, pursuing reimbursement pathways, and forging partnerships to scale precision oncology.

Our mission is simple: bring clarity to cancer care, advance translational research, and guide emerging diagnostics companies toward meaningful impact.

Stratifind

Org chart

Teams

Offices